D. Barr

Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains.

M. Kay, A. Lieber, A. Scaria, 1995, Gene therapy.

First‐pass metabolism of midazolam by the human intestine

D. Shen, C. Marsh, J. Perkins, 1996, Clinical pharmacology and therapeutics.

Identification of platelet-derived growth factor A and B chains in human renal vascular rejection.

C. Alpers, K. Hudkins, C. Marsh, 1996, The American journal of pathology.

First‐pass metabolism of midazolam by the human intestine

D. Shen, C. Marsh, J. Perkins, 1996, Clinical pharmacology and therapeutics.

Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes

M. Kay, S. Polyak, D. Gretch, 1996, Journal of virology.

Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.

W. Trager, D. Shen, C. Marsh, 1994, The Journal of pharmacology and experimental therapeutics.

Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.

W. Trager, D. Shen, C. Marsh, 1994, The Journal of pharmacology and experimental therapeutics.

Methods for delivery of genes to hepatocytes in vivo using recombinant adenovirus vectors.

M. Kay, D. Barr, 1997, Methods in molecular medicine.